Latham & Watkins advised Genascence in the transaction. Genascence Corporation (Genascence), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, has completed...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here